Skip to main content

Together we are beating cancer

Donate now

Chemotherapy

Showing 12 out of 185 results
Cancer Research UK logo

Chemotherapy given with shorter intervals between treatments than conventional chemotherapy increases survival rates by two thirds in children with high-risk neuroblastoma, according to a study published in the Lancet Oncology* today (Tuesday). Chemotherapy given with shorter intervals between treatments than conventional chemotherapy increases survival rates by two thirds in children with high-risk neuroblastoma, according to a study published in the Lancet Oncology* today (Tuesday).

by Cancer Research UK | News | 26 February 2008

26 February 2008

Cancer Research UK logo

Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology. Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.

by Cancer Research UK | News | 21 July 2007

21 July 2007

Cancer Research UK logo

Around 5,500 pre-menopausal patients could be offered a hormone drug that is shown to be as effective as traditional chemotherapy - and so avoid potential infertility and long-term menopausal side effects - according to a Cancer Research UK report published in The Lancet. Around 5,500 pre-menopausal patients could be offered a hormone drug that is shown to be as effective as traditional chemotherapy - and so avoid potential infertility and long-term menopausal side effects - according to a Cancer Research UK report published in The Lancet.

by Cancer Research UK | News | 18 May 2007

18 May 2007

Cancer Research UK logo

Children given chemotherapy before surgery to treat the most common form of childhood kidney cancer, called Wilms' tumour, require less treatment and experience fewer long term side effects than if they have immediate surgery, according to trial results revealed at today's NCRI Cancer Conference and published in the European Journal of Cancer. Children given chemotherapy before surgery to treat the most common form of childhood kidney cancer, called Wilms' tumour, require less treatment and experience fewer long term side effects than if they have immediate surgery, according to trial results revealed at today's NCRI Cancer Conference and published in the European Journal of Cancer.

by Cancer Research UK | News | 10 October 2006

10 October 2006

Cancer Research UK logo

Adding a new chemotherapy drug to standard treatment for advanced pancreatic cancer has shown dramatic improvement in survival, a new study from Cancer Research UK reveals today (Wednesday 2nd Nov). Adding a new chemotherapy drug to standard treatment for advanced pancreatic cancer has shown dramatic improvement in survival, a new study from Cancer Research UK reveals today (Wednesday 2nd Nov).

by Cancer Research UK | News | 2 November 2005

2 November 2005

Cancer Research UK logo

Cancer Research UK scientists hope to use a simple blood test to discover which ovarian cancer patients become resistant to chemotherapy - says a leading researcher at the charity's conference in Harrogate, Yorkshire. Cancer Research UK scientists hope to use a simple blood test to discover which ovarian cancer patients become resistant to chemotherapy - says a leading researcher at the charity's conference in Harrogate, Yorkshire.

by Cancer Research UK | News | 17 May 2004

17 May 2004

Cancer Research UK logo

Chemotherapy after surgery almost trebles survival rates for pancreatic cancer according to new research published in the New England Journal of Medicine 1. Chemotherapy after surgery almost trebles survival rates for pancreatic cancer according to new research published in the New England Journal of Medicine 1.

by Cancer Research UK | News | 17 March 2004

17 March 2004

Cancer Research UK logo

Stripping cancer cells of their defences against chemotherapy with a new class of anti-resistance drug has the potential to improve treatment for many solid tumours, Cancer Research UK scientists suggest. Stripping cancer cells of their defences against chemotherapy with a new class of anti-resistance drug has the potential to improve treatment for many solid tumours, Cancer Research UK scientists suggest.

by Cancer Research UK | News | 19 February 2004

19 February 2004

Cancer Research UK logo

Cancer Research UK scientists have discovered a key mechanism that protects lung cancer from the lethal effects of chemotherapy. Cancer Research UK scientists have discovered a key mechanism that protects lung cancer from the lethal effects of chemotherapy.

by Cancer Research UK | News | 4 November 2003

4 November 2003